A randomized controlled trial of genotypic HIV drug resistance testing in HIV-1-infected children: the PERA (PENTA 8) trial.

OBJECTIVE: To evaluate the longer-term utility of genotypic resistance testing in HIV-1-infected children with virological failure. METHODS: Children aged 3 months-18 years switching antiretroviral therapy (ART) with HIV-1 RNA > 2,000 copies/ml were randomized between genotypic testing (Virtu...

Full description

Bibliographic Details
Main Authors:	Green, H, Gibb, D, Compagnucci, A, Giacomet, V, de Rossi, A, Harper, L, Saïdi, Y, Castelli-Gattinara, G, Pillay, D, Babiker, A, Aboulker, J, Lyall, H, Bacheler, LT, Walker, A, Debré, M, Rosso, R, Burger, D, Della Negra, M, Dunn, D, Giaquinto, C
Format:	Journal article
Language:	English
Published:	2006

A randomized controlled trial of genotypic HIV drug resistance testing in HIV-1-infected children: the PERA (PENTA 8) trial.

Similar Items